In an era where biotechnology innovation is rapidly globalizing, having a robust intellectual property (IP) strategy is crucial for companies aiming to protect and leverage their innovations on the global stage. This interactive panel session invites IP experts from the US, China, Europe, India, and Korea to share insights on designing effective IP strategies that cater not only to domestic protection but also to global expansion. The discussion will focus on the nuances of obtaining IP protection for biotech platforms versus products, highlighting the key similarities and differences. Each country/region expert will elucidate what it means to “get it right” within their jurisdiction and advise on best practices for global IP management.